Literature DB >> 26095479

The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response.

Andrew B Kanouse, Peggy Compton.   

Abstract

Opioids are a mainstay in the treatment of pain both chronically and acutely. In the past 20 years, the prescribing of opioids has increased exponentially. As the population for whom opioids are indicated has grown, with the number of opioid prescriptions written increased, so have indicators of opioid misuse, abuse, morbidity, and mortality. The purpose of this article is to review and explore the combination of factors of events that led to the current "epidemic" of prescription opioid abuse and overdose deaths, as well as the subsequent resurgence of heroin use among opioid addicts. Federal initiatives to mount war on prescription opioid abuse are reviewed, including responses from the White House, Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), and interagency initiatives. Many initiatives are currently in place to combat the rising rates of morbidity and mortality associated with opioids, and those involved are hopeful in their efforts to curb the epidemic of this deadly phenomenon.

Entities:  

Keywords:  federal agencies; heroin; opioid abuse; pain; prescription opioids

Mesh:

Substances:

Year:  2015        PMID: 26095479     DOI: 10.3109/15360288.2015.1037521

Source DB:  PubMed          Journal:  J Pain Palliat Care Pharmacother        ISSN: 1536-0288


  33 in total

1.  Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors.

Authors:  Joseph J Palamar; Jenni A Shearston; Eric W Dawson; Pedro Mateu-Gelabert; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-11-21       Impact factor: 4.492

2.  Characterizing marijuana concentrate users: A web-based survey.

Authors:  Raminta Daniulaityte; Francois R Lamy; Monica Barratt; Ramzi W Nahhas; Silvia S Martins; Edward W Boyer; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2017-06-29       Impact factor: 4.492

3.  Prescription Opioid Epidemic: Do Veterinarians Have a Dog in the Fight?

Authors:  Derek S Mason; Liliana Tenney; Peter W Hellyer; Lee S Newman
Journal:  Am J Public Health       Date:  2018-09       Impact factor: 9.308

4.  Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US.

Authors:  Ty S Schepis; Christian J Teter; Linda Simoni-Wastila; Sean Esteban McCabe
Journal:  Addict Behav       Date:  2018-06-12       Impact factor: 3.913

5.  Machine learning for phenotyping opioid overdose events.

Authors:  Jonathan Badger; Eric LaRose; John Mayer; Fereshteh Bashiri; David Page; Peggy Peissig
Journal:  J Biomed Inform       Date:  2019-04-25       Impact factor: 6.317

Review 6.  Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.

Authors:  Jacob T Borodovsky; Sharon Levy; Marc Fishman; Lisa A Marsch
Journal:  J Addict Med       Date:  2018 May/Jun       Impact factor: 3.702

7.  Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III.

Authors:  Ty S Schepis; Sean Esteban McCabe
Journal:  J Clin Psychiatry       Date:  2019-11-19       Impact factor: 4.384

Review 8.  Methamphetamine and the risk of pulmonary arterial hypertension.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

9.  GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM): LESSONS LEARNED FROM AMERICA.

Authors:  Kenneth Blum; Edward J Modestino; Marjorie C Gondré-Lewis; Jennifer Neary; David Siwicki; Mary Hauser; Debmalya Barh; Bruce Steinberg; Rajendra D Badgaiyan
Journal:  Precis Med (Bangalore)       Date:  2017-11-18

10.  Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.

Authors:  L R Gerak; C P France
Journal:  J Pharmacol Exp Ther       Date:  2016-03-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.